Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer

por Miranda, E, Destro, A, Malesci, A, Balladore, E, Bianchi, P, Baryshnikova, E, Franchi, G, Morenghi, E, Laghi, L, Gennari, L, Roncalli, M
Publicado 2006

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

por Giovannetti, E, Zucali, P A, Assaraf, Y G, Leon, L G, Smid, K, Alecci, C, Giancola, F, Destro, A, Gianoncelli, L, Lorenzi, E, Roncalli, M, Santoro, A, Peters, G J
Publicado 2011

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

por Cappuzzo, F, Varella-Garcia, M, Finocchiaro, G, Skokan, M, Gajapathy, S, Carnaghi, C, Rimassa, L, Rossi, E, Ligorio, C, Di Tommaso, L, Holmes, A J, Toschi, L, Tallini, G, Destro, A, Roncalli, M, Santoro, A, Jänne, P A
Publicado 2008